106 related articles for article (PubMed ID: 16612443)
1. [NT pro-BNP levels in pericardial diseases and how they are used as complementary evaluation method of diastolic restriction. Initial experience: 25 cases].
Fernandes F; Almeida IJ; Ramires FJ; Buck PC; Salemi VM; Ianni BM; Rabelo R; Mady C
Arq Bras Cardiol; 2006 Mar; 86(3):175-80. PubMed ID: 16612443
[TBL] [Abstract][Full Text] [Related]
2. Serum NT pro-BNP: relation to systolic and diastolic function in cardiomyopathies and pericardiopathies.
Mady C; Fernandes F; Arteaga E; Ramires FJ; Buck Pde C; Salemi VM; Ianni BM; Nastari L; Dias RR
Arq Bras Cardiol; 2008 Jul; 91(1):46-54. PubMed ID: 18660945
[TBL] [Abstract][Full Text] [Related]
3. N-terminal prohormone brain natriuretic peptide (NT-proBNP) as a noninvasive marker for restrictive syndromes.
Mady C; Fernandes F; Ramires FJ; Nastari L; Buck PC; Arteaga E; Ianni BM; Salemi VM
Braz J Med Biol Res; 2008 Aug; 41(8):664-7. PubMed ID: 18797698
[TBL] [Abstract][Full Text] [Related]
4. Correlation between NT-pro BNP levels and early mitral annulus velocity (E') in patients with non-ST-segment elevation acute coronary syndrome.
Barbosa MM; Nunes Mdo C; Castro LR; Nominato LF; Alencar MC; Ribeiro AL
Echocardiography; 2008 Apr; 25(4):353-9. PubMed ID: 18177379
[TBL] [Abstract][Full Text] [Related]
5. NT pro B type natriuretic peptide levels in constrictive pericarditis and restrictive cardiomyopathy.
Parakh N; Mehrotra S; Seth S; Ramakrishnan S; Kothari SS; Bhargava B; Bahl VK
Indian Heart J; 2015; 67(1):40-4. PubMed ID: 25820049
[TBL] [Abstract][Full Text] [Related]
6. N-terminal pro-brain natriuretic peptide is related with coronary flow velocity reserve and diastolic dysfunction in patients with asymmetric hypertrophic cardiomyopathy.
Tesic M; Seferovic J; Trifunovic D; Djordjevic-Dikic A; Giga V; Jovanovic I; Petrovic O; Marinkovic J; Stankovic S; Stepanovic J; Ristic A; Petrovic M; Mujovic N; Vujisic-Tesic B; Beleslin B; Vukcevic V; Stankovic G; Seferovic P
J Cardiol; 2017 Oct; 70(4):323-328. PubMed ID: 28336204
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of N-terminal pro-type-B natriuretic peptide and Doppler left ventricular diastolic variables in patients with chronic systolic heart failure stabilized by therapy.
Dini FL; Conti U; Fontanive P; Andreini D; Panicucci E; De Tommasi SM
Am J Cardiol; 2008 Aug; 102(4):463-8. PubMed ID: 18678307
[TBL] [Abstract][Full Text] [Related]
8. Comparison of usefulness of tissue Doppler imaging versus brain natriuretic peptide for differentiation of constrictive pericardial disease from restrictive cardiomyopathy.
Sengupta PP; Krishnamoorthy VK; Abhayaratna WP; Korinek J; Belohlavek M; Sundt TM; Chandrasekaran K; Seward JB; Tajik AJ; Khandheria BK
Am J Cardiol; 2008 Aug; 102(3):357-62. PubMed ID: 18638602
[TBL] [Abstract][Full Text] [Related]
9. [Change in plasma N-terminal pro-brain natriuretic peptide in children with Kawasaki disease and its value in clinical practice].
Zhang QY; Du JB; Chen YH; Li WZ
Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):886-90. PubMed ID: 17254452
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of N-terminal pro-B-type natriuretic peptide levels to predict exercise capacity in hypertrophic cardiomyopathy.
Thaman R; Esteban MT; Barnes S; Gimeno JR; Mist B; Murphy R; Collinson PO; McKenna WJ; Elliott PM
Am J Cardiol; 2006 Aug; 98(4):515-9. PubMed ID: 16893708
[TBL] [Abstract][Full Text] [Related]
11. The role of N terminal pro-brain natriuretic peptide in the evaluation of left ventricular diastolic dysfunction: correlation with echocardiographic indexes in hypertensive patients.
Ceyhan C; Unal S; Yenisey C; Tekten T; Ceyhan FB
Int J Cardiovasc Imaging; 2008 Mar; 24(3):253-9. PubMed ID: 17687631
[TBL] [Abstract][Full Text] [Related]
12. Utility of plasma N-terminal brain natriuretic peptide as a marker of functional capacity in patients with chronic severe mitral regurgitation.
Yusoff R; Clayton N; Keevil B; Morris J; Ray S
Am J Cardiol; 2006 May; 97(10):1498-501. PubMed ID: 16679092
[TBL] [Abstract][Full Text] [Related]
13. Association of left ventricular diastolic dysfunction with elevated NT-pro-BNP in general intensive care unit patients with preserved ejection fraction: a complementary role of tissue Doppler imaging parameters and NT-pro-BNP levels for adverse outcome.
Ikonomidis I; Nikolaou M; Dimopoulou I; Paraskevaidis I; Lekakis J; Mavrou I; Tzanela M; Kopterides P; Tsangaris I; Armaganidis A; Kremastinos DT
Shock; 2010 Feb; 33(2):141-8. PubMed ID: 19487972
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major.
Kremastinos DT; Hamodraka E; Parissis J; Tsiapras D; Dima K; Maisel A
Am Heart J; 2010 Jan; 159(1):68-74. PubMed ID: 20102869
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of N-terminal pro-B-type natriuretic peptide in patients with active infective endocarditis.
Kahveci G; Bayrak F; Mutlu B; Bitigen A; Karaahmet T; Sonmez K; Izgi A; Degertekin M; Basaran Y
Am J Cardiol; 2007 May; 99(10):1429-33. PubMed ID: 17493474
[TBL] [Abstract][Full Text] [Related]
16. Comparison of pro B-natriuretic peptide in hypertensive patients with and without diastolic dysfunction.
Santosa YP; Tjandrawati A; Noormartany ; Erwinanto ; Yahya AF; Martanto E; Tedjokusumo P; Purnomowati A; Antono E
Acta Med Indones; 2008 Jan; 40(1):19-23. PubMed ID: 18326895
[TBL] [Abstract][Full Text] [Related]
17. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].
Zhang SR; Zhang YH; Xu Q; Qiu HX; Chen Q
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):429-32. PubMed ID: 19558803
[TBL] [Abstract][Full Text] [Related]
18. Use of cardiac markers for monitoring of doxorubixin-induced cardiotoxicity in children with cancer.
Pongprot Y; Sittiwangkul R; Charoenkwan P; Silvilairat S
J Pediatr Hematol Oncol; 2012 Nov; 34(8):589-95. PubMed ID: 23018571
[TBL] [Abstract][Full Text] [Related]
19. Plasma amino-terminal pro-B-type natriuretic peptide quantification in hypertrophic cardiomyopathy.
Arteaga E; Araujo AQ; Buck P; Ianni BM; Rabello R; Mady C
Am Heart J; 2005 Dec; 150(6):1228-32. PubMed ID: 16338263
[TBL] [Abstract][Full Text] [Related]
20. Reduction of N terminal-pro-brain (B-type) natriuretic peptide levels with exercise-based cardiac rehabilitation in patients with left ventricular dysfunction after myocardial infarction.
Giallauria F; De Lorenzo A; Pilerci F; Manakos A; Lucci R; Psaroudaki M; D'Agostino M; Del Forno D; Vigorito C
Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):625-32. PubMed ID: 16874155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
